Nanocrystals of thermodynamically stable alpha-MnAs (hexagonal NiAs-type) and metastable beta-MnAs (orthorhombic MnP-type) have been synthesized by the reaction of triphenylarsine oxide (Ph(3)AsO) and dimanganesedecacarbonyl (Mn(2)CO(10)) at temperatures ranging from 250 to 330 degrees C in the presence of the coordinating solvent trioctylphosphine oxide (TOPO). Morphologically, both alpha- and beta-MnAs nanoparticles adopt a core-shell type structure with a crystalline core and low-contrast noncrystalline shell. In contrast to prior studies on MnAs particles, disks, and films, the present bottom-up synthesis yields discrete, dispersible MnAs nanoparticles without a structural support. Even in the absence of epitaxial strain, the lattice parameters of the nanocrystals are decreased relative to bulk MnAs, resulting in a volume decrease of 0.35% in alpha-MnAs and 0.38% in beta-MnAs nanoparticles. In contrast to bulk MnAs, where the ferromagnetic phase transition upon warming through 313-317 K is concomitant with a structure change from ferromagnetic alpha- to paramagnetic beta-MnAs, powder X-ray diffraction studies suggest there is no conversion of alpha-MnAs to beta over the temperature range 298-343 K. Moreover, magnetic measurements suggest that both alpha- and beta-MnAs are ferromagnetic with T(C) approximately 315 K. Partial phase transformation of beta-MnAs nanoparticles into thermodynamically stable alpha-MnAs occurs slowly over time (i.e., months) at room temperature. However, there is no associated change in magnetization, suggesting the ferromagnetism observed in beta-MnAs is intrinsic and cannot be attributed to alpha-MnAs impurities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.